Why all randomised controlled trials produce biased results

References

• Andrew E, Anis A, Chalmers T, et al. A proposal for structured reporting of randomized controlled trials. JAMA. 1994;272:1926–1931.
   PubMed Web of Science ®Google Scholar
• Sackett D, Rosenberg W, Gray J, et al. Evidence-based medicine: what it is and what it isn’t. BMJ. 1996;312:71–72.
   PubMed Web of Science ®Google Scholar
• Djulbegovic B, Kumar A, Glasziou P, et al. Medical research: trial unpredictability yields predictable therapy gains. Nature. 2013;500:395–396.
   PubMed Web of Science ®Google Scholar
• Worrall J. Why there’s no cause to randomize. London: London School of Economics; Nov 2004. (Technical report 24/4).
   Google Scholar
• Seligman M. Science as an ally of practice. Am Psychol. 1996;51:1072–1079.
   PubMed Web of Science ®Google Scholar
• Duflo E, Glennerster R, Kremer M. Using randomization in development economics research: a toolkit. In: Handbook of development economics. Amsterdam: Elsevier; 2007.
   Google Scholar
• Banerjee A. Making aid work. Cambridge: MIT Press; 2007.
   Google Scholar
• Marler J. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–1588.
   PubMed Web of Science ®Google Scholar
• Van Den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–1367.
   PubMed Web of Science ®Google Scholar
• Slamon D, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against her2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001;344:783–792.
   PubMed Web of Science ®Google Scholar
• Rossouw J, Anderson G, Prentice R, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. JAMA. 2002;288:321–333.
   PubMed Web of Science ®Google Scholar
• Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335–2342.
   PubMed Web of Science ®Google Scholar
• Scandinavian Simvastatin Survival Study Group (SSSSG). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the scandinavian simvastatin survival study. Lancet. 1994;344:1383–1389.
   PubMed Web of Science ®Google Scholar
• Shepherd J, Cobbe S, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301–1308.
   PubMed Web of Science ®Google Scholar
• Diabetes Control and Complications Trial Research Group (DCC). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986.
   PubMed Web of Science ®Google Scholar
• Turner R. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998;352:837–853.
   PubMed Web of Science ®Google Scholar
• Knowler W, Barrett-Connor E, Fowler S, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.
   PubMed Web of Science ®Google Scholar
• Moher D, Hopewell S, Schulz K, et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.
   PubMed Web of Science ®Google Scholar
• Rennie D. CONSORT revised – improving the reporting of randomized trials. JAMA. 2001;285:2006–2007.
   PubMed Web of Science ®Google Scholar
• Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 1998;352:609–613.
   PubMed Web of Science ®Google Scholar
• Chan A, Altman D. Epidemiology and reporting of randomised trials published in PubMed journals. Lancet. 2005;365:1159–1162.
   PubMed Web of Science ®Google Scholar
• Vandenbroucke J. Observational research, randomised trials, and two views of medical science. PLoS Med. 2008;5:e67.
   PubMed Web of Science ®Google Scholar
• Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ. 1996;312:1215–1218.
   PubMed Web of Science ®Google Scholar
• Dwan K, Altman D, Arnaiz J, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One. 2008;3:e3081.
   PubMed Web of Science ®Google Scholar
• Goldacre B. Make journals report clinical trials properly. Nature. 2016;530:7.
   PubMed Web of Science ®Google Scholar
• Lawler P, Filion K, Eisenberg M. Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am Heart J. 2011;162:571–584.e2.
   PubMed Web of Science ®Google Scholar
• Altman D. Comparability of randomised groups. The Statistician. 1985;34:125–136.
   Google Scholar
• Cartwright N. Are RCTs the gold standard? Biosocieties. 2007;2:11–20.
   Google Scholar
• Bekelman J, Li Y, Gross C. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289:454–465.
   PubMed Web of Science ®Google Scholar
• Lexchin J, Bero L, Djulbegovic B, et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003;326:1167–1170.
   PubMed Web of Science ®Google Scholar
• Allison M. Reinventing clinical trials. Nat Biotechnol. 2012;30:41–49.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Wittes J. Interpreting geographic variations in results of randomized, controlled trials. N Engl J Med. 2016;375:2263–2271.
   PubMed Web of Science ®Google Scholar
• Pfeffer M, McMurray J. Lessons in uncertainty and humility – clinical trials involving hypertension. N Engl J Med. 2016;375:1756–1766.
   PubMed Web of Science ®Google Scholar